SCHEMBL28794193

SCHEMBL28794193

CC(=O)Oc1cc(-c2ccccc2)cc(NN)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ BACE1 P56817 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ ITGB3 P05106 1/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ HMGB1 P09429 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ GGT1 P19440 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ NAPRT Q6XQN6 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TOP1 P11387 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28796445 0.87 BACE1 (0.42) HDAC1HDAC3HDAC2BACE1KDM4E
SCHEMBL27748175 0.86 HDAC1 (0.52) HDAC1HDAC3HDAC2BACE1KDM4E
SCHEMBL27879328 0.81 ADORA1 (0.43) HDAC1BACE1KDM4EALDH1A1HPGD
SCHEMBL27769336 0.81 TDP1 (0.44) HDAC1HDAC3HDAC2BACE1KDM4E
SCHEMBL27769325 0.78 TDP1 (0.44) BACE1KDM4ETDP1ALDH1A1ESR1
SCHEMBL27848619 0.76 NPC1 (0.48) HDAC1HDAC3HDAC2KDM4EHSD17B10
SCHEMBL28781439 0.73 CRHBP (0.53) BACE1KDM4ETDP1ALDH1A1ESR1
SCHEMBL28005664 0.73 CFD (0.41) BACE1KDM4ETDP1ALDH1A1ESR1
SCHEMBL28794195 0.72 PTGS1 (0.64) HDAC1HDAC3HDAC2KDM4ETSHR
SCHEMBL27827831 0.72 ACHE (0.54) BACE1KDM4ETDP1ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101903359-B Triazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists HOFFMANN LA ROCHE 2013-05-22 — — CN disclosed
CN-101903359-A Triazole-substituted arylamide derivatives and their use as P2X3And/or P2X2/3Use of purinergic receptor antagonists HOFFMANN LA ROCHE 2010-12-01 — — CN disclosed
Send feedback